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A 15 year old youth, who presented with out-of-hospital 
cardiac arrest due to documented ventricular fibrilla•
tion, was found to have nonobstructive hypertrophic car•
diomyopathy. Electrophysiologic study demonstrated in•
ducible sustained atrial fibrillation with a rapid ventricular 
response. This rhythm, associated with hypotension and 
evidence of myocardial ischemia, spontaneously degen•
erated into ventricular fibrillation. No ventricular ar-
Sudden death is a well known complication of hypertrophic 
cardiomyopathy with or without obstruction (1-3). The 
mechanism in most cases is a primary ventricular arrhyth•
mia, presumably arising in the abnormal hypertrophied 
myocardium. Atrial arrhythmias, particularly atrial fibril•
lation, are also common in this group of patients, and al•
though often symptomatic, they are not associated with sud•
den death (3,4). We describe a 15 year old youth with 
nonobstructive hypertrophic cardiomyopathy who had an 
out-of-hospital cardiac arrest with documented ventricular 
fibrillation. On the basis of findings during electrophysio•
logic study, we postulate that the mechanism of the cardiac 
arrest was the onset of atrial fibrillation, with the devel•
opment of subsequent myocardial ischemia, leading to spon•
taneous degeneration to ventricular fibrillation. 
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rhythmias were inducible by programmed ventricular 
stimulation. Therapy with metoprolol and verapamil 
slowed the ventricular rate during atrial fibrillation and 
maintained hemodynamic stability, both during follow•
up electrophysiologic study and during a subsequent 
spontaneous episode. 
(J Am Coil CardioI1986;7:701-4) 
Case Report 
History. A 15 year old male patient was referred for 
evaluation and management after an out-of-hospital cardiac 
arrest. The patient sustained sudden loss of consciousness 
while jogging in his school gymnasium. The only premon•
itory symptom was a feeling of mild malaise before starting 
exercise. Cardiopulmonary resuscitation was begun, and on 
arrival of the emergency rescue personnel, the patient was 
documented to have ventricular fibrillation. Resuscitation 
was successful, but the patient's initial hospital course was 
complicated by hypoxic encephalopathy, pneumonia and 
bilateral pneumothorax, all of which resolved fully. The 
patient had no previous cardiovascular history or symptoms, 
and had engaged in normal physical activities without dif•
ficulty. He had a family history significant for the sudden 
death of a paternal uncle at 15 years of age. 
Physical examination. At the time of referral to this 
center, the patient was a tall, thin youth with a Marfanoid 
habitus, but no other clinical features of Marfan's syndrome. 
The pulse was 84 beats/min and regular, and blood pressure 
was 130/80 mm Hg, both supine and erect. The carotid 
pulses had a brisk upstroke but were not bisferiens. The left 
ventricular apical impulse was accentuated, and a grade 2/6 
systolic ejection murmur, heard maximally at the lower left 
sternal border, radiated to the apex and neck. The murmur 
did not vary with posture or the Val salva maneuver. The 
remainder of the physical examination was normal. 
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Investigations. The electrocardiogram showed sinus 
rhythm with a PR interval of 160 ms, a Q wave in lead 
a VL, nonspecific T wave inversion in the inferior limb and 
lateral precordial leads and left ventricular hypertrophy. 
Echocardiography revealed diffuse left ventricular hyper•
trophy with mild systolic anterior motion of the mitral valve 
consistent with hypertrophic cardiomyopathy. 
Cardiac catheterization demonstrated a diffusely and 
markedly hypertrophic left ventricle with an ejection frac•
tion of 65% and an end-diastolic pressure at rest of 8 mm 
Hg. No left ventricular outflow gradient could be demon•
strated in the rest state or provoked by Valsalva maneuver, 
ventricular extrasystoles, amyl nitrite or intravenous iso•
proterenol infusion. The coronary arteries were normal. 
Electrophysiologic study. After informed consent was 
obtained from both the patient and his parents, an electro•
physiologic study was performed in the sedated (diazepam), 
postabsorptive state, with the patient taking no cardioactive 
medication. Three quadripolar electrode catheters were in•
serted percutaneously and positioned to record high right 
atrial, His bundle and right ventricular apical electrograms. 
Incremental pacing and programmed right atrial stim•
ulation were performed. The minimal atrial paced cycle 
length with 1: 1 atrioventricular (A V) conduction was 300 
ms. The AH interval prolonged 40 ms from sinus rhythm 
Figure 1. Surface and intracardiac electrograms during atrial pac•
ing and atrial fibrillation. A, During right atrial pacing there is ST 
segment elevation in standard electrocardiographic leads I and II, 
and ST depression in lead VI. B, ST segment changes in the surface 
electrocardiograms persist during atrial fibrillation. C, After ther•
apy with metoprolol and verapamil, the ventricular rate during 
atrial fibrillation has slowed and the ST segment changes no longer 
occur. A = atrial activation; H = His bundle potential; HBE = 
HIS bundle electrogram: HRA = high right atrial electrogram; S 
= stimulus artifact during atrial pacing; V = right ventricular 
activation. 
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to right atrial pacing at 300 ms. The AH interval during 
sinus rhythm was 80 ms. Sinus node and His-Purkinje sys•
tem function were normal. During right atrial incremental 
pacing, ST segment elevation was observed in standard 
electrocardiographic leads I and II, and ST segment depres•
sion in lead VI (Fig. lA). 
Incremental pacing and programmed stimulation with 
single, double and triple extrastimuli at drive cycle lengths 
of 600 and 400 ms were performed from the right ventricular 
apex and outflow tract. Up to two bundle branch reentrant 
beats were recorded, but no significant ventricular arrhyth•
mias were induced. 
Rapid right atrial pacing at progressively accelerating 
rates was then performed and induced atrial fibrillation with 
a rapid ventricular rate of 180 to 190 beats/min. During 
rapid atrial pacing, ST segment changes were again ob•
served. After the induction of atrial fibrillation these changes 
persisted (Fig. 1 B), and the systolic blood pressure de•
creased to 70 mm Hg. The patient complained of substernal 
constricting chest discomfort, but was unaware of rapid 
heart action. After 100 seconds of this arrhythmia, there 
was a sudden degeneration of the cardiac rhythm to ven•
tricular fibrillation (Fig. 2) requiring electrical cardioversion 
with a 360 W-s shock to restore sinus rhythm. 
Serial electropharmacologic evaluation. The patient 
was started on treatment with metoprolol, 150 mg orally 
twice daily, and repeat electrophysiologic study was per•
formed after 6 days of this regimen. The shortest cycle 
length conducting 1: 1 through the A V node during right 
atrial pacing was 400 ms. Atrial flutter and fibrillation was 
again induced by rapid atrial pacing, with a ventricular rate 
of 130 to 140 beats/min and a systolic blood pressure of 80 
to 90 mm Hg. No chest pain, ST segment changes or ven•
tricular arrhythmias occurred. A further study was per•
formed after the patient was started on verapamil, 80 mg 
three times daily, in addition to the metoproloJ, 150 mg 
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Figure 2. After 100 seconds of induced atrial fibrillation, spon•
taneous degeneration to ventricular fibrillation occurs, indicated 
by the asterisk. Abbreviations as in Figure 1. 
twice daily. A V nodal conduction with atrial pacing was 
similar to that with metoprolol alone. Sustained atrial fi•
brillation was induced, with a ventricular rate of 90 to 105 
beats/min (Fig. 1C) and systolic blood pressure of 100 to 
105 mm Hg. The patient remained asymptomatic. 
Follow-up. The patient was discharged receiving com•
bined metoprolol and verapamil therapy, and during the 
follow-up period of 5 months had one spontaneous episode 
of atrial fibrillation. The ventricular rate remained at 95 to 
100/min, and the patient remained hemodynamically stable 
without symptoms. Electrical cardioversion restored normal 
sinus rhythm. 
Discussion 
Sudden death is not an uncommon complication of hy•
pertrophic cardiomyopathy and is usually attributed to a 
primary ventricular arrhythmia (1-3). Atrial arrhythmias are 
also a well recognized complication (3,4), but have not been 
associated with ventricular fibrillation in previous reports, 
except when an accessory atrioventricular (A V) pathway 
was present (5). Although atrial arrhythmias in patients with 
enhanced A V conduction have been documented to lead to 
ventricular fibrillation, none of the described patients had 
hypertrophic cardiomyopathy (6). 
Proposed mechanism of sudden cardiac arrest in this 
patient. Enhanced anterograde A V nodal conduction is de•
fined as: 1) AH intervals during sinus rhythm of 60 ms or 
less; 2) 1: 1 conduction between the atrium and His bundle 
at right atrial pacing cycle lengths of less than 300 ms; and 
3) subnormal prolongation of the AH interval with pacing 
( < lOOms difference between the AH interval during sinus 
rhythm and the AH interval during right atrial pacing at 300 
ms) (7). 
There are no age-adjusted criteria for enhanced antero•
grade A V conduction in adolescents. However, the age•
adjusted lower limit of normal PR interval in children aged 
6 to 16 is 100 ms (8). Pahlajani et al. (9) studied normal 
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A V conduction in children aged 8 months to 18 years. They 
found 1: 1 A V conduction at rates greater than 200 beats/min 
in 12 of 18 patients who had atrial pacing performed. How•
ever, all of their patients were premedicated with prometh•
azine (Phenergan) which may have atropine-like effects. 
Baseline AH intervals were normal (60 to 125 ms) in all 
but one of their patients. 
An anatomically small or immature A V node has been 
postulated as one of the causes of the Lown-Ganong-Levine 
syndrome in adults ( 10). Our patient's A V nodal conduction 
properties do not meet strict criteria for enhanced A V con•
duction (AH interval 80 ms) and most likely represent the 
physiologic enhancement seen at an early age. 
Electrophysiologic study has inferred an unusual mech•
anism for the onset of ventricular fibrillation in this young 
patient with nonobstructive hypertrophic cardiomyopathy. 
Physiologically enhanced anterograde A V nodal conduction 
was present, and both atrial pacing and induced atrial fi•
brillation resulted in rapid ventricular rates. During atrial 
fibrillation there was evidence of myocardial ischemia, with 
the appearance of ST segment changes on the surface elec•
trocardiogram and typical anginal-type chest pain. The sys•
temic hypotension that developed was most likely due to 
the rapid ventric,Iiar rate and to the loss of timed atrial 
systole during atrial fibrillation in a poorly compliant left 
ventricle dependent on atrial contraction for adequate filling. 
This vicious cycle of myocardial ischemia and hypotension 
resulted in the spontaneous degeneration of the cardiac rhythm 
to ventricular fibrillation. A recent report (11) supports the 
concept of myocardial ischemia occurring in patients with 
hypertrophic cardiomyopathy and normal coronary arteries, 
and suggests a multifactorial mechanism including inade•
quate coronary vasodilator reserve, elevated left ventricular 
filling pressure and possibly abnormal oxygen extraction. 
We postulate that this patient developed an initial episode 
of atrial fibrillation and was aware of malaise but not 
palpitation. Myocardial ischemia and hypotension, exac•
erbated by his subsequent physical exertion, precipitated 
ventricular fibrillation. This view is further supported by 
the subsequent clinical episode of spontaneous atrial 
fibrillation. 
Implications for therapy. This case illustrates the use 
of electrophysiologic testing for clarifying the mechanism 
of a cardiac arrest and guiding therapy. After the mechanism 
was determined, treatment was aimed at slowing A V nodal 
conduction and thus limiting the ventricular response rate 
during atrial fibrillation, preventing the hemodynamic com•
promise that had produced myocardial ischemia. A com•
bination of a beta-adrenoreceptor blocking drug (metopro-
101) and veraparnil was chosen, and this treatment successfully 
slowed the ventricular rate and limited hypotension during 
the arrhythmia. These drugs improve the left ventricular 
diastolic pressure-volume relation (12) and also minimize 
the hemodynamic cycle leading to myocardial ischemia. 
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This case emphasizes the potentially life-threatening nature 
of atrial fibrillation developing in patients with hypertrophic 
cardiomyopathy. If there is hemodynamic compromise with 
this arrhythmia, prompt electrical cardioversion is indicated. 
We are grateful to lacqueline Perez and lanet Fossum for preparation of 
the manuscript. 
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